Total Valuation
Advanced Biomed Inc. has a market cap or net worth of $10.54M. The enterprise value is $5.08M.
Market Cap$10.54M
Enterprise Value$5.08M
Share Statistics
Advanced Biomed Inc. has 1,652,133 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,652,133
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Advanced Biomed Inc.’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -1.98%.
Return on Equity (ROE)-0.03
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)-1.98%
Return on Capital Employed (ROCE)-0.03
Revenue Per Employee0.00
Profits Per Employee-3.27K
Employee Count31
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Advanced Biomed Inc. is ―. Advanced Biomed Inc.’s PEG ratio is -9.28.
PE Ratio―
PS Ratio0.00
PB Ratio4.36
Price to Fair Value4.36
Price to FCF-83.03
Price to Operating Cash Flow-12.50
PEG Ratio-9.28
Income Statement
In the last 12 months, Advanced Biomed Inc. had revenue of 0.00 and earned -101.52K in profits. Earnings per share was -0.09.
Revenue0.00
Gross Profit-10.71K
Operating Income-94.11K
Pretax Income-101.52K
Net Income-101.52K
EBITDA-83.40K
Earnings Per Share (EPS)-0.09
Cash Flow
In the last 12 months, operating cash flow was -691.70K and capital expenditures -2.90K, giving a free cash flow of -694.59K billion.
Operating Cash Flow-691.70K
Free Cash Flow-694.59K
Free Cash Flow per Share-0.42
Dividends & Yields
Advanced Biomed Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.36
52-Week Price Change-25.47%
50-Day Moving Average8.85
200-Day Moving Average6.21
Relative Strength Index (RSI)40.43
Average Volume (3m)142.99K
Important Dates
Advanced Biomed Inc. upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Advanced Biomed Inc. as a current ratio of 2.09, with Debt / Equity ratio of 7.74%
Current Ratio2.09
Quick Ratio2.09
Debt to Market Cap0.08
Net Debt to EBITDA19.65
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Advanced Biomed Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Advanced Biomed Inc. EV to EBITDA ratio is -161.98, with an EV/FCF ratio of -74.04.
EV to Sales0.00
EV to EBITDA-161.98
EV to Free Cash Flow-74.04
EV to Operating Cash Flow-74.44
Balance Sheet
Advanced Biomed Inc. has $2.60M in cash and marketable securities with $712.53K in debt, giving a net cash position of $1.89M billion.
Cash & Marketable Securities$2.60M
Total Debt$712.53K
Net Cash$1.89M
Net Cash Per Share$1.14
Tangible Book Value Per Share$3.21
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Advanced Biomed Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―